Hip Arthropathy Clinical Trial
Official title:
Comparison of the Constituents of Bone Marrow Aspirate and Autologous Protein Solution Collected With a Traditional and a Novel System
Six patients with diagnosed bone loss of the hip who have consented to minimally invasive repair will be approached to participate in the study. Participants will have the liquid portion of bone marrow collected using the Zimmer Biomet Biocue system, which is the standard system used by physicians at The Ohio State University, and the novel Marrow Cellutions system™. Bone marrow liquid will be collected from the surgical hip using the Zimmer Biomet Biocue system, and the Marrow Cellutions system™ will be used to collect bone marrow liquid from the non-surgical hip. Following collection, the bone marrow liquid will be processed using the respective systems to concentrate the cells and molecules found in the bone marrow liquid. As part of the standard of care for this arthroscopic procedure, concentrated bone marrow liquid processed using the Zimmer Biomet Biocue system will be delivered to the surgical site as an adjunct to promote healing. Concentrated bone marrow liquid prepared with the Zimmer Biomet Biocue system is given as part of the standard of care for patients undergoing minimally invasive treatment for bone loss of the hip; therefore, the target population for this study are individuals between the ages of 18-50 years with confirmed bone loss of the hip who have consented to minimally invasive repair. In addition to the concentrated bone marrow liquid prepared using the Zimmer Biomet Biocue system, patients will also have bone marrow liquid collected from the non-surgical hip using the Marrow Cellutions™ system. Only concentrated bone marrow liquid produced with the Zimmer Biomet Biocue system will be given to the patient. All concentrated bone marrow liquid produced with the Marrow Cellutions™ system will be sent to the laboratory for analysis. Additionally, white blood cells will be concentrated into an autologous protein solution (APS) using the Zimmer Biomet Plasmax system from blood collected using a routine blood draw. All protein solution produced will be sent to the laboratory for analysis. No protein solution will be given to the patient. As the bone marrow liquid collection using the Marrow Cellutions™ system and the blood draw to produce protein solution using the Zimmer Biomet Plasmax system are being performed for research,
l ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05556759 -
Anterior Iliopsoas Muscle Space Block Versus Supra-iliac Anterior Quadratus Lumborum Block in Total Hip Arthroplasty
|
N/A | |
| Withdrawn |
NCT05030688 -
Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty
|
N/A | |
| Not yet recruiting |
NCT05015517 -
ESP Block vs FIB in Patients Undergoing Hip Arthroplasty
|
N/A | |
| Completed |
NCT05134207 -
The Effect of Oral Carbohydrate Solution on Anxiety and Comfort in Patients Undergoing Hip Arthroplasty
|
N/A | |
| Recruiting |
NCT04438265 -
Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment
|
||
| Recruiting |
NCT04229368 -
Effect of Vitamin D Status and Repletion on Postoperative Total Joint Arthroplasty Complications
|
N/A | |
| Active, not recruiting |
NCT05142462 -
Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup
|
||
| Active, not recruiting |
NCT06083428 -
Erector Spinae vs. PENG Block for Total Hip Arthroplasty
|
Phase 4 | |
| Completed |
NCT05396924 -
Rectal Temperature Measurement in Detecting Hypothermia During Hip Arthroscopy
|
N/A | |
| Active, not recruiting |
NCT05524363 -
Assessment of Safety and Performances of HYPE SCS Stem Associated to NOVAE Sunfit TH Acetabular Cup in Hip Arthroplasty
|
||
| Recruiting |
NCT06147401 -
Comparison of PENG Associated With LFCN Block Versus FICB for Multimodal Analgesic Management in THA
|
N/A | |
| Completed |
NCT03977454 -
Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty
|
Phase 2 | |
| Recruiting |
NCT05397145 -
Iliopsoas Plane Block vs PENG Block for Hip Arthroplasty
|
N/A | |
| Completed |
NCT03981354 -
Nutritional Status and Its Modifications After Hip Replacement
|
||
| Active, not recruiting |
NCT04995822 -
Post Market Clinical Follow-up of EUROSTEM Femoral Stem
|
||
| Completed |
NCT04883788 -
The Impact of COVID-19 Pandemic on Hip and Knee Replacement
|
||
| Not yet recruiting |
NCT06317870 -
Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty
|
N/A | |
| Completed |
NCT03541798 -
Comparison of Three Different Sitting Positions for Performing Combined Spinal-Epidural Anesthesia
|
N/A | |
| Completed |
NCT04306133 -
PENG Block Combined to Wound Infiltration for Hip Replacement
|
N/A | |
| Completed |
NCT04123873 -
Effect of Combinations of Paracetamol, Ibuprofen, and Dexamethasone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip Arthroplasty
|
Phase 4 |